In addition to SFN, DIM also targeted Nrf2 via epigenetic modification and exerted chemopreventive effects in prostate cancer cells and in transgenic adenocarcinoma of mouse prostate (TRAMP) mice in vivo [158]. Here, NFE2L2 is linked to Familial prostate cancer.